However, while the presented data indicate a role of heterocellular OSM–OSMR signalling as a regulator of inflammatory fibroblasts, future studies will be critical to establish whether OSM–OSMR signalling directly involving tumour cells and other stromal cell populations play additional roles in PDA. This evidence concerns the gene OSM and Patent ductus arteriosus.